<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>HelioFlux 5-Year Strategic Roadmap</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: linear-gradient(135deg, #0a1628 0%, #1a365d 50%, #0a1628 100%);
            min-height: 100vh;
            color: #e2e8f0;
            padding: 20px;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
        }
        
        header {
            text-align: center;
            padding: 40px 20px;
            margin-bottom: 40px;
        }
        
        .logo {
            font-size: 3rem;
            font-weight: 700;
            background: linear-gradient(135deg, #60a5fa, #34d399);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
            margin-bottom: 10px;
        }
        
        .tagline {
            font-size: 1.3rem;
            color: #94a3b8;
            margin-bottom: 20px;
        }
        
        .headline {
            font-size: 1.1rem;
            color: #60a5fa;
            font-weight: 600;
        }
        
        .stats-row {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin-bottom: 50px;
        }
        
        .stat-card {
            background: rgba(30, 58, 95, 0.6);
            border: 1px solid rgba(96, 165, 250, 0.3);
            border-radius: 16px;
            padding: 25px;
            text-align: center;
        }
        
        .stat-value {
            font-size: 2.5rem;
            font-weight: 700;
            color: #60a5fa;
        }
        
        .stat-label {
            color: #94a3b8;
            font-size: 0.9rem;
            margin-top: 5px;
        }
        
        .section-title {
            font-size: 1.8rem;
            color: #60a5fa;
            margin-bottom: 25px;
            padding-bottom: 10px;
            border-bottom: 2px solid rgba(96, 165, 250, 0.3);
        }
        
        /* Timeline */
        .timeline {
            position: relative;
            margin: 50px 0;
        }
        
        .timeline-track {
            display: grid;
            grid-template-columns: repeat(4, 1fr);
            gap: 15px;
        }
        
        .phase-card {
            background: rgba(30, 58, 95, 0.8);
            border-radius: 16px;
            padding: 25px;
            border: 2px solid;
            position: relative;
            transition: transform 0.3s ease;
        }
        
        .phase-card:hover {
            transform: translateY(-5px);
        }
        
        .phase-1 { border-color: #34d399; }
        .phase-2 { border-color: #60a5fa; }
        .phase-3 { border-color: #f472b6; }
        .phase-4 { border-color: #fbbf24; }
        
        .phase-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 15px;
        }
        
        .phase-name {
            font-size: 1.3rem;
            font-weight: 700;
        }
        
        .phase-1 .phase-name { color: #34d399; }
        .phase-2 .phase-name { color: #60a5fa; }
        .phase-3 .phase-name { color: #f472b6; }
        .phase-4 .phase-name { color: #fbbf24; }
        
        .phase-amount {
            font-size: 1.1rem;
            font-weight: 600;
            color: #e2e8f0;
            background: rgba(0,0,0,0.3);
            padding: 5px 12px;
            border-radius: 20px;
        }
        
        .phase-timeline {
            color: #94a3b8;
            font-size: 0.85rem;
            margin-bottom: 15px;
        }
        
        .phase-focus {
            font-size: 1rem;
            color: #e2e8f0;
            font-weight: 600;
            margin-bottom: 12px;
        }
        
        .phase-items {
            list-style: none;
        }
        
        .phase-items li {
            padding: 6px 0;
            color: #94a3b8;
            font-size: 0.9rem;
            border-bottom: 1px solid rgba(255,255,255,0.1);
        }
        
        .phase-items li:last-child {
            border-bottom: none;
        }
        
        /* Cancer Grid */
        .cancer-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 15px;
            margin: 30px 0;
        }
        
        .cancer-card {
            background: rgba(30, 58, 95, 0.6);
            border-radius: 12px;
            padding: 20px;
            text-align: center;
            border: 1px solid rgba(96, 165, 250, 0.2);
        }
        
        .cancer-icon {
            font-size: 2rem;
            margin-bottom: 10px;
        }
        
        .cancer-name {
            font-weight: 600;
            color: #e2e8f0;
            margin-bottom: 5px;
        }
        
        .cancer-timing {
            font-size: 0.8rem;
            color: #60a5fa;
        }
        
        .cancer-card.active {
            border-color: #34d399;
            background: rgba(52, 211, 153, 0.1);
        }
        
        .cancer-card.active .cancer-timing {
            color: #34d399;
        }
        
        /* Treatment Section */
        .treatment-section {
            background: linear-gradient(135deg, rgba(244, 114, 182, 0.1), rgba(96, 165, 250, 0.1));
            border: 2px solid rgba(244, 114, 182, 0.3);
            border-radius: 20px;
            padding: 35px;
            margin: 40px 0;
        }
        
        .treatment-title {
            color: #f472b6;
            font-size: 1.5rem;
            margin-bottom: 20px;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .treatment-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
        }
        
        .treatment-column h4 {
            color: #94a3b8;
            margin-bottom: 15px;
            font-size: 0.9rem;
            text-transform: uppercase;
            letter-spacing: 1px;
        }
        
        .treatment-column ul {
            list-style: none;
        }
        
        .treatment-column li {
            padding: 8px 0;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .old-way {
            color: #ef4444;
            text-decoration: line-through;
            opacity: 0.7;
        }
        
        .new-way {
            color: #34d399;
        }
        
        /* Funding Sources */
        .funding-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }
        
        .funding-card {
            background: rgba(30, 58, 95, 0.6);
            border-radius: 12px;
            padding: 20px;
            border-left: 4px solid #60a5fa;
        }
        
        .funding-source {
            font-weight: 700;
            color: #60a5fa;
            font-size: 1.1rem;
        }
        
        .funding-amount {
            color: #34d399;
            font-size: 1.2rem;
            font-weight: 600;
            margin: 8px 0;
        }
        
        .funding-desc {
            color: #94a3b8;
            font-size: 0.85rem;
        }
        
        /* Footer */
        footer {
            text-align: center;
            padding: 40px;
            color: #64748b;
            border-top: 1px solid rgba(255,255,255,0.1);
            margin-top: 50px;
        }
        
        footer a {
            color: #60a5fa;
            text-decoration: none;
        }
        
        /* Mobile */
        @media (max-width: 900px) {
            .timeline-track {
                grid-template-columns: 1fr;
            }
            
            .treatment-grid {
                grid-template-columns: 1fr;
            }
            
            .logo {
                font-size: 2rem;
            }
        }
        
        /* Arrow indicator */
        .arrow-right {
            color: #60a5fa;
            font-size: 1.5rem;
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <div class="logo">‚òÄÔ∏è HelioFlux</div>
            <p class="tagline">Biophotonic Cancer Detection & Treatment</p>
            <p class="headline">See cancer before it sees you. Treat it before it spreads.</p>
        </header>
        
        <div class="stats-row">
            <div class="stat-card">
                <div class="stat-value">100x</div>
                <div class="stat-label">Earlier Detection</div>
            </div>
            <div class="stat-card">
                <div class="stat-value">10K</div>
                <div class="stat-label">Cells vs 1M Traditional</div>
            </div>
            <div class="stat-card">
                <div class="stat-value">$5-10M</div>
                <div class="stat-label">5-Year Program</div>
            </div>
            <div class="stat-card">
                <div class="stat-value">5+</div>
                <div class="stat-label">Cancer Types</div>
            </div>
        </div>
        
        <h2 class="section-title">üìÖ 5-Year Strategic Roadmap</h2>
        
        <div class="timeline">
            <div class="timeline-track">
                <div class="phase-card phase-1">
                    <div class="phase-header">
                        <span class="phase-name">Phase 1</span>
                        <span class="phase-amount">$500K-$1M</span>
                    </div>
                    <div class="phase-timeline">Months 1-18</div>
                    <div class="phase-focus">Detection Validation</div>
                    <ul class="phase-items">
                        <li>‚úì Melanoma study (n=100)</li>
                        <li>‚úì Brain cancer study (n=50)</li>
                        <li>‚úì Chemo brain detection</li>
                        <li>‚úì Peer-reviewed publications</li>
                        <li>‚úì FDA pre-submission</li>
                    </ul>
                </div>
                
                <div class="phase-card phase-2">
                    <div class="phase-header">
                        <span class="phase-name">Phase 2</span>
                        <span class="phase-amount">$1.5-$2.5M</span>
                    </div>
                    <div class="phase-timeline">Months 18-36</div>
                    <div class="phase-focus">Multi-Cancer Expansion</div>
                    <ul class="phase-items">
                        <li>‚Üí Breast cancer</li>
                        <li>‚Üí Lung cancer</li>
                        <li>‚Üí Pancreatic cancer</li>
                        <li>‚Üí Colorectal cancer</li>
                        <li>‚Üí Multi-site clinical network</li>
                    </ul>
                </div>
                
                <div class="phase-card phase-3">
                    <div class="phase-header">
                        <span class="phase-name">Phase 3</span>
                        <span class="phase-amount">$2-$3M</span>
                    </div>
                    <div class="phase-timeline">Months 30-48</div>
                    <div class="phase-focus">üéØ TREATMENT Development</div>
                    <ul class="phase-items">
                        <li>‚ö° EM cancer reprogramming</li>
                        <li>‚ö° Photobiomodulation</li>
                        <li>‚ö° First-in-human trial</li>
                        <li>‚ö° Combination therapy</li>
                        <li>‚ö° IND application</li>
                    </ul>
                </div>
                
                <div class="phase-card phase-4">
                    <div class="phase-header">
                        <span class="phase-name">Phase 4</span>
                        <span class="phase-amount">$1.5-$2.5M</span>
                    </div>
                    <div class="phase-timeline">Months 42-60</div>
                    <div class="phase-focus">Commercialization</div>
                    <ul class="phase-items">
                        <li>‚òÖ FDA clearance (detection)</li>
                        <li>‚òÖ FDA clearance (treatment)</li>
                        <li>‚òÖ 10+ cancer centers</li>
                        <li>‚òÖ Manufacturing scale</li>
                        <li>‚òÖ Reimbursement codes</li>
                    </ul>
                </div>
            </div>
        </div>
        
        <h2 class="section-title">üéØ Cancer Expansion Timeline</h2>
        
        <div class="cancer-grid">
            <div class="cancer-card active">
                <div class="cancer-icon">üî¨</div>
                <div class="cancer-name">Melanoma</div>
                <div class="cancer-timing">NOW ‚úì</div>
            </div>
            <div class="cancer-card active">
                <div class="cancer-icon">üß†</div>
                <div class="cancer-name">Brain / GBM</div>
                <div class="cancer-timing">NOW ‚úì</div>
            </div>
            <div class="cancer-card">
                <div class="cancer-icon">üíó</div>
                <div class="cancer-name">Breast</div>
                <div class="cancer-timing">Year 2</div>
            </div>
            <div class="cancer-card">
                <div class="cancer-icon">ü´Å</div>
                <div class="cancer-name">Lung</div>
                <div class="cancer-timing">Year 2</div>
            </div>
            <div class="cancer-card">
                <div class="cancer-icon">üî∂</div>
                <div class="cancer-name">Pancreatic</div>
                <div class="cancer-timing">Year 2-3</div>
            </div>
            <div class="cancer-card">
                <div class="cancer-icon">üü§</div>
                <div class="cancer-name">Colorectal</div>
                <div class="cancer-timing">Year 2-3</div>
            </div>
        </div>
        
        <div class="treatment-section">
            <h3 class="treatment-title">‚ö° The Treatment Revolution (Phase 3)</h3>
            <div class="treatment-grid">
                <div class="treatment-column">
                    <h4>Current Cancer Treatment</h4>
                    <ul>
                        <li><span class="old-way">‚ùå Detect tumor late stage</span></li>
                        <li><span class="old-way">‚ùå Surgery (invasive)</span></li>
                        <li><span class="old-way">‚ùå Chemotherapy (toxic)</span></li>
                        <li><span class="old-way">‚ùå Radiation (damages tissue)</span></li>
                        <li><span class="old-way">‚ùå Monitor every 3-6 months</span></li>
                    </ul>
                </div>
                <div class="treatment-column">
                    <h4>HelioFlux Future</h4>
                    <ul>
                        <li><span class="new-way">‚úì Detect at earliest cells</span></li>
                        <li><span class="new-way">‚úì No surgery (cells reprogrammed)</span></li>
                        <li><span class="new-way">‚úì EM treatment (non-toxic)</span></li>
                        <li><span class="new-way">‚úì Light-based (precise)</span></li>
                        <li><span class="new-way">‚úì Real-time monitoring</span></li>
                    </ul>
                </div>
            </div>
        </div>
        
        <h2 class="section-title">üí∞ Non-Dilutive Funding Targets</h2>
        
        <div class="funding-grid">
            <div class="funding-card">
                <div class="funding-source">ARPA-H</div>
                <div class="funding-amount">$2-5M</div>
                <div class="funding-desc">PREPARE program, high-risk/high-reward innovation</div>
            </div>
            <div class="funding-card">
                <div class="funding-source">NIH / NCI</div>
                <div class="funding-amount">$1-2M</div>
                <div class="funding-desc">R01, R21, SBIR/STTR grants</div>
            </div>
            <div class="funding-card">
                <div class="funding-source">DOD CDMRP</div>
                <div class="funding-amount">$500K-1.5M</div>
                <div class="funding-desc">Breast, brain, lung cancer programs</div>
            </div>
            <div class="funding-card">
                <div class="funding-source">BARDA</div>
                <div class="funding-amount">$1-3M</div>
                <div class="funding-desc">Diagnostic/therapeutic platform development</div>
            </div>
            <div class="funding-card">
                <div class="funding-source">Congressional</div>
                <div class="funding-amount">$1-5M</div>
                <div class="funding-desc">Directed appropriations opportunities</div>
            </div>
            <div class="funding-card">
                <div class="funding-source">NSF SBIR</div>
                <div class="funding-amount">$250-500K</div>
                <div class="funding-desc">Phase I/II small business grants</div>
            </div>
        </div>
        
        <footer>
            <p><strong>HelioFlux</strong> | Biophotonic Cancer Detection & Treatment</p>
            <p style="margin-top: 10px;">Contact: <a href="mailto:kelly.lucas@helioflux.co">kelly.lucas@helioflux.co</a></p>
            <p style="margin-top: 20px; font-size: 0.8rem;">Prepared for The Conafay Group | February 2026</p>
        </footer>
    </div>
</body>
</html>
